+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurodiagnostics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 5020927
  • Report
  • March 2020
  • Region: Global
  • 100 Pages
  • Infinium Global Research

FEATURED COMPANIES

  • Canon, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Mitsar Co., Ltd.
  • Ridge Diagnostics, Inc.
  • Siemens Healthineers AG
The report on the global neurodiagnostics market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global neurodiagnostics market to grow with a CAGR of 8.3% over the forecast period from 2019-2025. The study on neurodiagnostics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on neurodiagnostics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global neurodiagnostics market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global neurodiagnostics market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • Rising prevalence of neurological diseases and disorders
  • Growing advancement in genomics and proteomics for the diagnosis of neurodegenerative disorders
  • Prevalence of various diseases such as strokes, sleep disorders, narcolepsy, and multiple sclerosis

2) Restraints
  • High cost of neurodiagnostic devices

3) Opportunities
  • Rising applications in clinical trials

Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global neurodiagnostics market is segmented on the basis of technology type, disease type, and end-user.

The Global Neurodiagnostics Market by Technology Type
  • Neuroimaging
  • Nuclear Medicine Imaging
  • Electro-encephalography
  • Magneto-encephalography
  • Other Neuroimaging Technologies
  • In Vitro Diagnosis
  • Genetic Testing
  • Protein Biomarker Assay
  • Other in Vitro Diagnosis
  • Neuroinformatics

The Global Neurodiagnostics Market by Disease Type
  • Migraine
  • Multiple Sclerosis
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Depression
  • Other Diseases

The Global Neurodiagnostics Market by End-user
  • Neurology Centers
  • Diagnostic Laboratories and Imaging Centers
  • Hospitals and Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories

Company Profiles
The companies covered in the report include
  • Ridge Diagnostics, Inc.
  • Zynex NeuroDiagnostics, Inc.
  • Digital NeuroDiagnostics, LLC
  • NeuroDiagnostics Devices Inc.
  • Lifelines Neurodiagnostics Systems Inc.
  • GE Healthcare
  • Siemens Healthineers AG
  • Canon, Inc.
  • F. Hoffmann-La Roche AG
  • Mitsar Co., Ltd.
  • Other companies

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the neurodiagnostics market.
2. Complete coverage of all the segments in the neurodiagnostics market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global neurodiagnostics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Canon, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Mitsar Co., Ltd.
  • Ridge Diagnostics, Inc.
  • Siemens Healthineers AG

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Neurodiagnostics Market Highlights
2.2. Neurodiagnostics Market Projection
2.3. Neurodiagnostics Market Regional Highlights
3. Global Neurodiagnostics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Technology Type
3.4.2. Growth Matrix Analysis by Disease Type
3.4.3. Growth Matrix Analysis by End-user
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Neurodiagnostics Market
4. Neurodiagnostics Market Macro Indicator Analysis
5. Global Neurodiagnostics Market by Technology Type
5.1. Neuroimaging
5.1.1. Nuclear Medicine Imaging
5.1.2. Electro-encephalography
5.1.3. Magneto-encephalography
5.1.4. Other Neuroimaging Technologies
5.2. In Vitro Diagnosis
5.2.1. Genetic Testing
5.2.2. Protein Biomarker Assay
5.2.3. Other in Vitro Diagnosis
5.3. Neuroinformatics
6. Global Neurodiagnostics Market by Disease Type
6.1. Migraine
6.2. Multiple Sclerosis
6.3. Alzheimer’s Disease
6.4. Parkinson’s Disease
6.5. Depression
6.6. Other Diseases
7. Global Neurodiagnostics Market by End-user
7.1. Neurology Centers
7.2. Diagnostic Laboratories and Imaging Centers
7.3. Hospitals and Surgical Centers
7.4. Ambulatory Care Centers
7.5. Research Laboratories
8. Global Neurodiagnostics Market by Region 2019-2025
8.1. North America
8.1.1. North America Neurodiagnostics Market by Technology Type
8.1.2. North America Neurodiagnostics Market by Disease Type
8.1.3. North America Neurodiagnostics Market by End-user
8.1.4. North America Neurodiagnostics Market by Country
8.2. Europe
8.2.1. Europe Neurodiagnostics Market by Technology Type
8.2.2. Europe Neurodiagnostics Market by Disease Type
8.2.3. Europe Neurodiagnostics Market by End-user
8.2.4. Europe Neurodiagnostics Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Neurodiagnostics Market by Technology Type
8.3.2. Asia-Pacific Neurodiagnostics Market by Disease Type
8.3.3. Asia-Pacific Neurodiagnostics Market by End-user
8.3.4. Asia-Pacific Neurodiagnostics Market by Country
8.4. RoW
8.4.1. RoW Neurodiagnostics Market by Technology Type
8.4.2. RoW Neurodiagnostics Market by Disease Type
8.4.3. RoW Neurodiagnostics Market by End-user
8.4.4. RoW Neurodiagnostics Market by Sub-region
9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Neurodiagnostics Market
9.2. Companies Profiled
9.2.1. Ridge Diagnostics, Inc.
9.2.2. Zynex NeuroDiagnostics, Inc.
9.2.3. Digital NeuroDiagnostics, LLC
9.2.4. NeuroDiagnostics Devices Inc.
9.2.5. Lifelines Neurodiagnostics Systems Inc.
9.2.6. GE Healthcare
9.2.7. Siemens Healthineers AG
9.2.8. Canon, Inc.
9.2.9. F. Hoffmann-La Roche AG
9.2.10. Mitsar Co., Ltd.
9.2.11. Other companies
10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
  • Ridge Diagnostics, Inc.
  • Zynex NeuroDiagnostics, Inc.
  • Digital NeuroDiagnostics, LLC
  • NeuroDiagnostics Devices Inc.
  • Lifelines Neurodiagnostics Systems Inc.
  • GE Healthcare
  • Siemens Healthineers AG
  • Canon, Inc.
  • F. Hoffmann-La Roche AG
  • Mitsar Co., Ltd.
Note: Product cover images may vary from those shown